Abstract Titles

Skip to Late-Breaking Abstracts »

All accepted abstracts will be available in the Journal for ImmunoTherapy of Cancer (JITC).

Abstract Titles

Onsite Posters

Onsite posters will be presented in the Poster Hall at the Walter E. Washington Convention Center in Washington, D.C. All odd numbered posters will be presented on Friday, Nov. 12, 2021. Even numbered posters will be presented Saturday, Nov. 13, 2021.


ePosters will be on display on the SITC 2021 virtual meeting platform from 7 a.m. EST on Friday, Nov. 12, 2021 until the virtual meeting platform is closed on Jan. 9, 2022.

Search word or phrase:

# Type Title Authors Category Keywords
434 Poster Presentation Phase 1/2 study to evaluate pepinemab in combination with pembrolizumab in advanced, recurrent or metastatic head and neck cancer (KEYNOTE B84) Elizabeth E. Evans, PhD; Terrence L. Fisher, Jr., PhD; Crystal Mallow, BS; Amber Foster; Ernest S. Smith, PhD; John E. Leonard, MD PhD; Marya F. Chaney, PhD; Maurice Zauderer, PhD Clinical Trials In Progress Antibody;Antigen presenting cells;Biomarkers;Checkpoint blockade;Clinical trial;Immune suppression;MDSC;Myeloid cells;Tumor infiltrating lymphocytes (TILs);Tumor microenvironment